Pediatric Cancer in the 21st Century:
Harnessing Science to Improve Outcomes
The Washington Academy of Sciences (WAS) and American Association for the Advancement of Science (AAAS) sponsored a symposium at the AAAS headquarters auditorium on October 19, 2012.
Dr. David Poplack
Director of Texas Children’s Cancer Center
What Genomic Approaches are Telling us About Pediatric Cancer
Donald “Will” Parsons, M.D., Ph.D.
Assistant Professor of Pediatrics – hematology/oncology, Baylor College of Medicine
Dr. Donald W. (Will) Parsons
Donald Williams (Will) Parsons, M.D., Ph.D. is a board-certified pediatric hematologist-oncologist specializing in the care of children with brain and spinal cord tumors. His scientific interest is in the clinical applications of genomic medicine.
Engineering the Immune System to Treat Pediatric Cancer
Crystal Mackall, M.D.
Chief, Pediatric Oncology Branch, National Cancer Institute
Dr. Crystal L. Mackall was Chief of the Pediatric Oncology Branch of the National Cancer Institute and is internationally recognized for her work in tumor immunology and immune therapy.
Challenges in Developing New Therapies for Pediatric Cancer
Malcolm Smith, M.D., Ph.D.
Associate Branch Chief, Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute
Dr. Malcolm A. Smith is Associate Branch Chief, Clinical Investigations Branch Cancer Therapy Evaluation Program, National Cancer Institute (NCI). Dr. Smith has been at the NCI since 1990. He has been instrumental in developing NCI’s preclinical and clinical research programs for children with cancer.
Using the Internet to Guide Cancer Survivor Care
David Poplack, M.D.
Director of Texas Children’s
Cancer Center, Texas Children’s Hospital,
Baylor College of Medicine
Dr. David Poplack is Director of Texas Children’s Cancer Center, and the Elise C. Young Professor of Pediatric Oncology at Baylor College of Medicine.
The WAS and AAAS gratefully acknowledge the presenters for accepting our invitations to participate in this symposium.